Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

A legally valid consent form for PRP injections was created to improve communication and protect against lawsuits.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

New method accurately measures finasteride in tablets.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Standard nail varnish effectively prevents follicular penetration of certain substances.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

The UK Intellectual Property Office allows granting of supplementary protection certificates with negative terms.

Intense pulsed light with radiofrequency showed mixed results in improving quality of life for hidradenitis suppurativa patients, with no clinical improvements.

The new patch for treating mouth sores releases medicine slowly, sticks well, and helps healing without the side effects of current creams.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Created microspheres show potential for safe and effective use in prostate artery embolization.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

The new baby shampoo and wash with stearic acid is safe and potentially effective for nourishing babies' skin.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

The GNP crosslinked scaffold with antibacterial coating is effective for rapid wound healing and infection prevention.

The material improved facial wrinkles and skin appearance.

Bubble microneedles effectively deliver drugs through the skin and mouth, improving treatment speed and efficiency.